Abstract
Background: In hip fracture surgery, blood transfusions are commonly reported postoperatively. Allogenic blood transfusions can be associated with adverse effects, so their use should be reduced where possible. This study will focus on outcomes following the use of perioperative tranexamic acid (TXA) with the primary aim of assessing transfusion rates and thromboembolic events.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
